1KEN | date | ![]() |
|||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | |||||||||||||||||||
compound | source | ||||||||||||||||||
symmetry |
| ||||||||||||||||||
crystal cell |
| ||||||||||||||||||
method | X-Ray Diffraction | resolution | |||||||||||||||||
ligand | MAN, NAG | enzyme |
| ||||||||||||||||
Gene Ontology ![]() |
| ||||||||||||||||||
Primary reference | An antibody that prevents the hemagglutinin low pH fusogenic transition., Barbey-Martin C, Gigant B, Bizebard T, Calder LJ, Wharton SA, Skehel JJ, Knossow M, Virology 2002 Mar 1;294(1):70-4. PMID:11886266 |
Data retrieval |
![]() |
View 1KEN in 3D |
![]() |
Structure-derived information |
Sequence-derived information |
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |